Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Andrea Pettenazzo is active.

Publication


Featured researches published by Andrea Pettenazzo.


Gene Therapy | 1997

ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo

Stefano Ferrari; Enrico Moro; Andrea Pettenazzo; Behr Jp; Franco Zacchello; Maurizio Scarpa

Nonviral vectors might represent a safe alternative to adenovirus for gene therapy of lung disorders, in particular cystic fibrosis (CF). Cationic lipids have been shown to correct the CF defect both in vitro and in vivo, but more efficient vectors are needed to improve the low gene transfer efficiency. Here, we show that the cationic polymer ExGen 500, a linear polyethylenimine derivative, is more efficient than cationic lipids in transferring reporter genes to lung epithelial cells in vitro. In vivo ExGen 500 was able to mediate gene transfer into both newborn and adult rabbit lungs with comparable efficiencies. The best levels of transfection were obtained using neutral complexes. Under such conditions, luciferase activities corresponding to about 103 RLU/10 s/mg of protein were reproducibly obtained 2 days after transfection throughout the four lung lobes of newborn and adult rabbits. A nlslacZ reporter gene showed transfected cells around the lumen of large and small bronchi. No signs of acute toxicity (inflammation, cellular infiltration etc) were detected by direct histopathological analysis. Within 1 week after instillation, transgene expression decreased by two orders of magnitude.


Transplantation | 2009

One Liver for Four Children: First Clinical Series of Liver Cell Transplantation for Severe Neonatal Urea Cycle Defects

Jochen Meyburg; Anibh M. Das; Friederike Hoerster; Martin Lindner; Heinz Kriegbaum; Guido Engelmann; Jan Schmidt; Michael Ott; Andrea Pettenazzo; Thomas Luecke; Harald Bertram; Georg F. Hoffmann; Alberto Burlina

Background. Urea cycle disorders (UCD) have a poor prognosis despite dietary and pharmacologic therapy, especially if the onset of the disease is within the neonatal period. They are promising target diseases for liver cell transplantation (LCT), which may be a less invasive alternative or supplementation to orthotopic liver transplantation. Methods. Cryopreserved hepatocytes were isolated under good manufacturing practice conditions. Four children with severe neonatal UCD (age 1 day–3 years) received multiple intraportal infusions of cryopreserved hepatocytes from that same donor, a 9-day old neonate. Portal vein access was achieved surgically in two children, whereas the umbilical vein was suitable for interventional catheter placement in two neonates. Cell applications were carefully monitored by means of Doppler ultrasound and portal vein pressure. Results. LCT was feasible in all children. No signs of portal vein thrombosis or extrahepatic shunting were observed. All children showed metabolic stabilization during observation periods of 4 to 13 months. One child with prenatally diagnosed ornithine transcarbamylase deficiency died after 4 months from a fatal metabolic decompensation. Conclusions. Given the poor prognosis of UCD with conservative therapy, LCT caused considerable beneficial effects. Periods of hyperammonemia and clinically relevant crises could be reduced during an observation period of up to 13 months. Though cell therapy is not a permanent therapeutic option, bridging to liver transplantation may be substantially improved.


Biochimica et Biophysica Acta | 1999

Polyethylenimine shows properties of interest for cystic fibrosis gene therapy

Stefano Ferrari; Andrea Pettenazzo; Nicoletta Garbati; Franco Zacchello; Jean-Paul Behr; Maurizio Scarpa

Before being considered for a cystic fibrosis (CF) gene therapy trial, any gene delivery agent must be able to show that it produces low levels of toxicity as well as being able to protect the DNA from nuclease degradation. Here we show that complexes of linear polyethylenimine (L-PEI) and DNA can repeatedly be administered to animals (up to 21 consecutive days) without eliciting an immune response against PEI/DNA particles or inducing toxic side effects due to accumulation of PEI in the lungs. However, the host response to the exogenous protein resulted in some decrease of expression. PEI-mediated transfection was unaffected by treatment of the complexes with DNase (frequently used to reduce the viscosity of lung secretions in CF patients). Taken together, these properties make L-PEI a valuable vector for gene therapy of CF.


The Annals of Thoracic Surgery | 2008

Liver and Cardiac Function in the Long Term After Fontan Operation

Sonia Camposilvan; Ornella Milanesi; Giovanni Stellin; Andrea Pettenazzo; Lucia Zancan; Lorenzo D'Antiga

BACKGROUND Patients who underwent Fontan operation have some degree of liver disease. We aimed to assess the long-term liver and cardiac function after Fontan operation. METHODS Patients enrolled underwent physical examination, biochemical tests (aspartate aminotransferase, alanine aminotransferase, gamma glutamyl transpeptidase, bilirubin, international normalized ratio, coagulation factor V, protein profile, fecal alpha-1-antitrypsin), echocardiogram, and liver ultrasonography. A liver disease score was adopted to compare the degree of liver involvement with hemodynamic features. RESULTS The study enrolled 34 patients, median age 14.7 years (range, 4.1 to 26.7), 26 with a residual left ventricle, 8 with a residual right ventricle, affected by tricuspid atresia (17), pulmonary atresia (4), hypoplastic left heart syndrome (5), double-outlet right ventricle (2), single left ventricle (2), and miscellaneous (4), with median follow-up of 11.5 years (range, 1.7 to 23.3). We found hepatomegaly in 18 of 34 (53%), splenomegaly in 3 of 33 (9%), abnormal transaminases in 10 of 33 (30%), elevated gamma GT in 19 of 31 (61%), elevated bilirubin in 10 of 31 (32%), coagulopathy in 17 of 29 (58%), and protein-losing enteropathy in 4 of 21 (19%). Median heart rate z-score was -1.72. Hepatic dysfunction was strictly correlated to low cardiac index (r(2) = 0.34, p = 0.008) and to a lesser extent to reduced heart rate (r(2) = 0.18, p = 0.07). CONCLUSIONS In children who underwent Fontan operation, hepatic dysfunction is correlated with low cardiac index and reduced heart rate. Maintaining or reestablishing a normal cardiac index might prevent or reduce liver disease in the long-term.


Intensive Care Medicine | 1996

Nitric oxide 2

Gerfried Zobel; A. Gamillscheg; B. Urlesberger; Siegfried Rödl; Drago Dacar; J. Berger; Helfried Metzler; A. Beitzke; Bruno Rigler; M. Trop; H. M. Grubbauer; Allan Goldman; Robert C. Tasker; S Hosiasson; T Henrichsen; Duncan Macrae; Philippe Jouvet; J. M. Treluyer; E. Werner; P. Hubert; J. Pfenninger; D. C. G. Bachmann; Bendicht Wagner; Sylvia Göthberg; Karl Erik Edberg; Swee Fong Tang; Daniel Holmgren; Svein Michelsen; Owen I Miller; Erik Thaulow

Introduction: Permissive hypercapnia (PH) is a beneficial strategy for patients with acute respiratory distress syndrome (ARDS) to minimize barotrauma by decreasing the peak inspiratory pressure (PIP). Hypercapnia and hypoxia cause pulmonary vasoconstriction, pulmonary artery (PA) hypertension, and, thus, an increased afterload to the right ventricle. This increased afterload may result in increased right ventricular (RV) work load and subsequent RV dysfunction. One therapeutic approach is the use of inhaled nitric oxide (iNO), a selective PA vasodilator. The objectives of this study were to test the hypothesis that in a swine model of ARDS with PH, iNO would improve RV work load and not change intrinsic RV contractility. Methods: In 11 swine (25-35 kg), ARDS was induced by surfactant depletion. Hypercapnia was achieved by decreasing the PIP while increasing the PEEP to maintain a constant mean airway pressure. iNO was administered in concentrations of 2, 5, and 10 ppm in a random order, Pulmonary blood flow (Qpa) was determined by an ultrasonic flow probe. RV total power (TP) and stroke work (SW) were calculated by Fourier transformation of the PA pressure (Ppa) and Qpa data. Preload recruitable stroke work (PRSW), a preload and afterload independent measure of ventricular contractility, was determined by a shell-subtraction method and vena caval occlusion) Results: Data are represented as mean ± sent and compared by two-way analysis of variance with repeated measures. (* n < 0.05 vs. 0 nnm) 0 ppm 2 ppm 5 ppm 10 ppm er s*1000 /mL 24.6 ± 1.6 25.2 ± 2.4 23.3 ± 1.8 22.9 ± 2.5 mW 92±11 74±6* 66±6 75±8* [RSW


Biochemical Pharmacology | 2011

Amiodarone impairs trafficking through late endosomes inducing a Niemann-Pick C-like phenotype

Elena Piccoli; Matteo Nadai; Carla Mucignat Caretta; Valeria Bergonzini; Claudia Del Vecchio; Huy Riem Ha; Laurent Bigler; Daniele Dal Zoppo; Elisabetta Faggin; Andrea Pettenazzo; Rocco Orlando; Cristiano Salata; Arianna Calistri; Giorgio Palù; Aldo Baritussio

Abstract Patients treated with amiodarone accumulate lysobisphosphatidic acid (LBPA), also known as bis(monoacylglycero)phosphate, in airway secretions and develop in different tissues vacuoles and inclusion bodies thought to originate from endosomes. To clarify the origin of these changes, we studied in vitro the effects of amiodarone on endosomal activities like transferrin recycling, Shiga toxin processing, ESCRT-dependent lentivirus budding, fluid phase endocytosis, proteolysis and exosome secretion. Furthermore, since the accumulation of LBPA might point to a broader disturbance in lipid homeostasis, we studied the effect of amiodarone on the distribution of LBPA, unesterified cholesterol, sphingomyelin and glycosphyngolipids. Amiodarone analogues were also studied, including the recently developed derivative dronedarone. We found that amiodarone does not affect early endosomal activities, like transferrin recycling, Shiga toxin processing and lentivirus budding. Amiodarone, instead, interferes with late compartments of the endocytic pathway, blocking the progression of fluid phase endocytosis and causing fusion of organelles, collapse of lumenal structures, accumulation of undegraded substrates and amassing of different types of lipids. Not all late endocytic compartments are affected, since exosome secretion is spared. These changes recall the Niemann-Pick type-C phenotype (NPC), but originate by a different mechanism, since, differently from NPC, they are not alleviated by cholesterol removal. Studies with analogues indicate that basic pKa and high water-solubility at acidic pH are crucial requirements for the interference with late endosomes/lysosomes and that, in this respect, dronedarone is at least as potent as amiodarone. These findings may have relevance in fields unrelated to rhythm control.


Journal of Child Neurology | 2014

Intrathecal synthesis of oligoclonal bands in rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation syndrome: new evidence supporting immunological pathogenesis.

Stefano Sartori; Elena Priante; Andrea Pettenazzo; P. Marson; Agnese Suppiej; Franca Benini; Giorgio Perilongo; Irene Toldo

Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation syndrome (ROHHADS) is a rare, but potentially lethal, pediatric disorder. To date, nearly 80 patients have been reported in the literature; however, the etiopathogenesis is still unclear and debated. Both genetic and paraneoplastic or immune-mediated causes have been supposed to be involved in this syndrome. Nonetheless, at this time, a diagnostic biomarker is not available and diagnosis is based exclusively on clinical criteria. Aiming to establish the immune-mediated pathogenesis, we report 2 children with a clinical picture consistent with ROHHADS and whose cerebrospinal fluid analysis disclosed an intrathecal synthesis of oligoclonal bands. Even if many aspects remain to be explained, this finding suggests that ROHHADS could share similar pathogenetic mechanisms with other immune-mediated central nervous system disorders, and even more important, it might pave the way to a therapeutic chance for these patients by means of immunotherapy.


American Journal of Respiratory Cell and Molecular Biology | 2008

Amiodarone Alters Late Endosomes and Inhibits SARS Coronavirus Infection at a Post-Endosomal Level

Konrad Stadler; Huy Riem Ha; Vincenzo Ciminale; Carlo Spirli; Giulietta Saletti; Marco Schiavon; Daniela Bruttomesso; Laurent Bigler; Ferenc Follath; Andrea Pettenazzo; Aldo Baritussio

Amiodarone interferes with the endocytic pathway, inhibits proteolysis, and causes the formation of vacuoles, but uptake and intracellular distribution of the drug, origin of vacuoles, and functional consequences of amiodarone accumulation remain unclear. Our objective was to study amiodarone uptake, clarify the origin of vacuoles, and investigate the effect of amiodarone on the life cycle of the coronavirus responsible for the Severe Acute Respiratory Syndrome (SARS), which, to enter cells, relies on the proteolytic cleavage of a viral spike protein by the endosomal proteinase cathepsin L. Using alveolar macrophages, we studied uptake of (125)I-amiodarone and (125)I-B2, an analog lacking the lateral group diethylamino-beta-ethoxy, and analyzed the effects of amiodarone on the distribution of endosomal markers and on the uptake of an acidotropic dye. Furthermore, using Vero cells, we tested the impact of amiodarone on the in vitro spreading of the SARS coronavirus. We found that (1) amiodarone associates with different cell membranes and accumulates in acidic organelles; (2) the diethylamino-beta-ethoxy group is an important determinant of uptake; (3) vacuoles forming upon exposure to amiodarone are enlarged late endosomes; (4) amiodarone inhibits the spreading in vitro of SARS coronavirus; and (5) trypsin cleavage of the viral spike protein before infection, which permits virus entry through the plasma membrane, does not impair amiodarone antiviral activity. We conclude that amiodarone alters late compartments of the endocytic pathway and inhibits SARS coronavirus infection by acting after the transit of the virus through endosomes.


BMJ Open | 2016

Efficacy of ketamine in refractory convulsive status epilepticus in children: a protocol for a sequential design, multicentre, randomised, controlled, open-label, non-profit trial (KETASER01).

Anna Rosati; Lucrezia Ilvento; Manuela L'Erario; Salvatore De Masi; Annibale Biggeri; Giancarlo Fabbro; Roberto Bianchi; Francesca Stoppa; Lucia Fusco; Silvia Pulitanò; Domenica Battaglia; Andrea Pettenazzo; Stefano Sartori; Paolo Biban; Elena Fontana; Elisabetta Cesaroni; Paola Costa; Rosanna Meleleo; Roberta Vittorini; Alessandra Conio; Andrea Wolfler; Massimo Mastrangelo; Maria Cristina Mondardini; Emilio Franzoni; Kathleen S. McGreevy; Lorena Di Simone; Alessandra Pugi; Lorenzo Mirabile; Federico Vigevano; Renzo Guerrini

Introduction Status epilepticus (SE) is a life-threatening neurological emergency. SE lasting longer than 120 min and not responding to first-line and second-line antiepileptic drugs is defined as ‘refractory’ (RCSE) and requires intensive care unit treatment. There is currently neither evidence nor consensus to guide either the optimal choice of therapy or treatment goals for RCSE, which is generally treated with coma induction using conventional anaesthetics (high dose midazolam, thiopental and/or propofol). Increasing evidence indicates that ketamine (KE), a strong N-methyl-d-aspartate glutamate receptor antagonist, may be effective in treating RCSE. We hypothesised that intravenous KE is more efficacious and safer than conventional anaesthetics in treating RCSE. Methods and analysis A multicentre, randomised, controlled, open-label, non-profit, sequentially designed study will be conducted to assess the efficacy of KE compared with conventional anaesthetics in the treatment of RCSE in children. 10 Italian centres/hospitals are involved in enrolling 57 patients aged 1 month to 18 years with RCSE. Primary outcome is the resolution of SE up to 24 hours after withdrawal of therapy and is updated for each patient treated according to the sequential method. Ethics and dissemination The study received ethical approval from the Tuscan Paediatric Ethics Committee (12/2015). The results of this study will be published in peer-reviewed journals and presented at international conferences. Trial registration number NCT02431663; Pre-results.


Early Human Development | 1985

The effect of a ‘containing’ position in a hammock versus the supine position on the cutaneous oxygen level in premature and term babies

Michele Bottos; Andrea Pettenazzo; Giuseppe Giancola; Daniela Stefani; Gianna Pettenà; Bruno Viscolani; Firmino F. Rubaltelli

We evaluated the influence of positioning, and particularly a containing position in a hammock compared with the supine position, on the respiration of the newborn. Recordings of the transcutaneous oxygen level of 40 preterm babies and 10 full-term babies placed in their incubators alternately in the two positions have been analyzed. We found no significant differences between the means of the oxymetric indexes in the hammock and in the supine position, even when the babies had different gestational ages and birth weights. The advantages of the containing position for the neuromotor and relational development of the newborn in the first year of life in comparison with the effects of supine placement, which should be avoided as much as possible in the premature, are pointed out.

Collaboration


Dive into the Andrea Pettenazzo's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge